Application 050726

Type
NDA
Sponsor
NEOPHARMA

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001AUGMENTIN '200'AMOXICILLIN; CLAVULANATE POTASSIUMTABLET, CHEWABLE;ORAL200MG;EQ 28.5MG BASEYesNo
002AUGMENTIN '400'AMOXICILLIN; CLAVULANATE POTASSIUMTABLET, CHEWABLE;ORAL400MG;EQ 57MG BASEYesNo

Source provenance: Browse the complete Orange Book source catalog · source snapshot 44.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N050726-001AUGMENTIN '200'AMOXICILLIN; CLAVULANATE POTASSIUM200MG;EQ 28.5MG BASETABLET, CHEWABLE / ORALRLD1996-05-31
N050726-002AUGMENTIN '400'AMOXICILLIN; CLAVULANATE POTASSIUM400MG;EQ 57MG BASETABLET, CHEWABLE / ORALRLD1996-05-31

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 3 of 3 · 88 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2022-10-28 04:53 UTC2022-10N050726-001AUGMENTIN '200'200MG;EQ 28.5MG BASETABLET, CHEWABLE / ORALRLD1996-05-31f41ea6bd6efb…
2022-10-28 04:53 UTC2022-10N050726-002AUGMENTIN '400'400MG;EQ 57MG BASETABLET, CHEWABLE / ORALRLD1996-05-31f41ea6bd6efb…
2022-09-29 23:25 UTC2022-09N050726-001AUGMENTIN '200'200MG;EQ 28.5MG BASETABLET, CHEWABLE / ORALRLD1996-05-31e64feba35796…
2022-09-29 23:25 UTC2022-09N050726-002AUGMENTIN '400'400MG;EQ 57MG BASETABLET, CHEWABLE / ORALRLD1996-05-31e64feba35796…
2022-07-09 03:26 UTC · 3 captures of this ZIP2022-07N050726-001AUGMENTIN '200'200MG;EQ 28.5MG BASETABLET, CHEWABLE / ORALRLD1996-05-31cb3db0bc1861…
2022-07-09 03:26 UTC · 3 captures of this ZIP2022-07N050726-002AUGMENTIN '400'400MG;EQ 57MG BASETABLET, CHEWABLE / ORALRLD1996-05-31cb3db0bc1861…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06N050726-001AUGMENTIN '200'200MG;EQ 28.5MG BASETABLET, CHEWABLE / ORALRLD1996-05-31a50c72e98297…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06N050726-002AUGMENTIN '400'400MG;EQ 57MG BASETABLET, CHEWABLE / ORALRLD1996-05-31a50c72e98297…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
78375SUPPL 2024-05-02
78368SUPPL 2024-05-02
71950SUPPL2022-08-29
71932SUPPL2022-08-26
30393SUPPL2013-01-24
8132SUPPL2013-01-24
18137SUPPL2013-01-23
18136SUPPL2013-01-23
18135SUPPL2011-10-18
8131SUPPL2011-10-04
8130SUPPL2008-12-11
18133SUPPL2008-12-08
30392SUPPL2008-04-02
18134SUPPL2008-03-27
8129SUPPL2004-08-12
8128SUPPL2004-06-07
30390SUPPL2004-05-27
30391SUPPL2003-06-08